12th European AIDS Conference / EACS
Webcasted Presentation

Search’n Build™

Atazanavir/ritonavir monotherapy for maintenance of virologic suppression: 48 week primary analysis of the 96 week multicenter, open-label, single-arm, pilot OREY study

Dr. Federico Pulido
Dr. Federico Pulido
Madrid, Spain  
13 slide(s) – 00:07:09 – English – 2009-11-12
Extra Features Available

VIDEO PODCAST

SLIDE LIBRARY
A A A  
Rate: Not useful Somewhat useful Mostly useful Useful Very useful

Please let us know how useful this content was for you
and feel free to write your comments below.